← Open Payments lookup

GREGORY LUNCEFORD: Open Payments

NPI 1851373047 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$681 in 34 payments from 8 companies in 2025. Trend: 2023 $629 · 2024 $819 · 2025 $681

Food & beverage: $681
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.7$182
ABBVIE INC.12$150
E.R. Squibb & Sons, L.L.C.4$94
Neurocrine BioSciences, Inc.3$86
Otsuka America Pharmaceutical, Inc.3$66
Alkermes, Inc.2$51
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$32
Tris Pharma Inc1$20

Products named: VRAYLAR, AUSTEDO XR, COBENFY, INGREZZA, ARISTADA, UZEDY, REXULTI, CAPLYTA.

Industry payments across GA — which companies pay providers there.